Proteomic Biomarker Analytics Markets: Forecasts by Application, Technology, Product and Place with Executive and Consultant Guides 2022 to 2026
Publication date: May 2023
“Proteomic analytics is replacing genomics as the new frontier in biotechnology. Early days hold plenty of opportunity with completely new types of biomarkers already at work…..”
- Who will be the Illumina of proteomics?
- Will these new biomarkers redefine disease definitions?
- Will proteomic assays displace current genomic assays?
Proteomic biomarker analytics is just finding its feet, but the opportunity is to understand the front line players, with the actual proteins and protein complexes that do the work of managing cellular life. Players are reporting double digit growth with Venture Capital well involved. Learn about this market including the issues and outlooks. This technology could possibly displace most cancer diagnostic protocols AND save money at the same time.
- Drug discovery
- Clinical diagnostics
- Mass Spectrometry
- Hybrid multiplex
- Kits and reagents
- Pharma and biotech
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional and co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell is a member of The American Association for Clinical Chemistry. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School